Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing Functional Impairments in Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN)

NCT07315334 is registered in ClinicalTrials.gov with Paracelsus Medical University as lead sponsor.

NCT NCT07315334
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07315334 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing Functional Impairments in Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN)
Lead sponsor
Paracelsus Medical University
Phase
Observational
Overall status
Recruiting
Start date
March 15, 2026
Completion date
March 31, 2027
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy induced peripheral neuropathy (cipn)